Increased placental growth factor (PlGF) concentrations in children and adolescents with obesity and the metabolic syndrome

Hormones

Volumn 13, Issue 3, 2014, Pages 369-374

  Pervanidou, Panagiota ^a   Chouliaras, Giorgos ^a   Akalestos, Athanassios ^b   Bastaki, Despoina ^a   Apostolakou, Filia ^b   Papassotiriou, Ioannis ^b   Chrousos, George P ^a,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Angiogenesis; Cardiovascular risk; Children; Metabolic syndrome; Obesity; PlGF; Troponin

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; BIOLOGICAL MARKER; PLACENTA PROTEIN; PLACENTAL GROWTH FACTOR;

ADOLESCENT; AGE DISTRIBUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIRTH LENGTH; BIRTH WEIGHT; BODY HEIGHT; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DOWN REGULATION; DRUG EFFICACY; DRUG RESPONSE; FAMILY HISTORY; FOLLOW UP; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HORMONE SUBSTITUTION; HUMAN; ITALY; LONG TERM CARE; MALE; POPULATION RESEARCH; PREVALENCE; PROTEIN BLOOD LEVEL; PUBERTY; SCHOOL CHILD; SHORT STATURE; VERNAL CONJUNCTIVITIS; AGE; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; METABOLIC SYNDROME X; PEDIATRIC OBESITY; PREDICTIVE VALUE; RISK FACTOR; UPREGULATION;

ADOLESCENT; AGE FACTORS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; HUMANS; METABOLIC SYNDROME X; PEDIATRIC OBESITY; PREDICTIVE VALUE OF TESTS; PREGNANCY PROTEINS; RISK FACTORS; UP-REGULATION;

EID: 84904568973     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1491     Document Type: Article

References (30)

1. Bridger T, 2009 Childhood obesity and cardiovascular disease. Paediatr Child Health 14: 177-182.
2. Kassi e, Pervanidou P, Kaltsas G, Chrousos G, 2011 Metabolic syndrome: definitions and controversies. BMC Med 9: 48.
3. Carmeliet P, 2003 angiogenesis in health and disease. nat Med 9: 653-660.
4. Sandhofer a, Tatarczyk T, Kirchmair r, et al, 2009 are plasma veGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SaPHir study. atherosclerosis 206: 265-269.
5. dewerchin M, Carmeliet P, 2012 PlGF: a multitasking cytokine with disease-restricted activity. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a011056 (in press).
6. Cassidy a, Chiuve Se, Manson Je, rexrode KM, Girman CJ, rimm eB, 2009 Potential role for plasma placental growth factor in predicting coronary heart disease risk in women. arterioscler Thromb vasc Biol 29: 134-139.
7. Pelisek J, Well G, reeps C, et al, 2012 neovasculariza tion and angiogenic factors in advanced human carotid artery stenosis. Circ J 76: 1274-1282.
8. Hausman GJ, richardson rL, 2004 adipose tissue angiogenesis. J anim Sci 82: 925-934.
9. Makey KL, Patterson SG, robinson J, et al, 2013 increased plasma levels of soluble vascular endothelial growth factor receptor 1 (sFlt-1) in women by moderate exercise and increased plasma levels of vascular endothelial growth factor in overweight/obese women. eur J Cancer Prev 22: 83-89.
10. Siervo M, ruggiero d, Sorice r, et al, 2012 Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents. nutrition 28: 262-266.
11. Kaess BM, Pedley a, Massaro JM, et al, 2012 relation of vascular growth factors with CT-derived measures of body fat distribution: the Framingham Heart Study J Clin endocrinol Metab 97: 987-994.
12. Cullberg KB, Christiansen T, Paulsen SK, Bruun JM, Pedersen SB, richelsen B, 2013 effect of weight loss and exercise on angiogenic factors in the circulation and in adipose tissue in obese subjects. obesity (Silver Spring) 21: 454-460.
13. Khurana r, Moons L, Shafi S, et al, 2005 Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation. Circulation 111: 2828-2836.
14. Christiaens v, Lijnen Hr, 2010 angiogenesis and development of adipose tissue. Mol Cell endocrinol 318: 2-9.
15. Lijnen Hr, Christiaens v, Scroyen i, et al, 2006 impaired adipose tissue development in mice with inactivation of placental growth factor function. diabetes 55: 2698-2704.
16. Siervo M, ruggiero d, Sorice r, et al, 2010 angiogenesis and biomarkers of cardiovascular risk in adults with metabolic syndrome. J intern Med 268: 338-347.
17. Pervanidou P, akalestos a, Bastakid, apostolakouF, Papassotirioui, Chrousos GP, 2013 increased Circulating High Sensitivity-Troponin (hs-TnT) Concentrations in Children and adolescents with obesity and the Metabolic Syndrome: a Marker for early Cardiac damage? Metabolism 62: 527-531.
18. Cole TJ, Bellizzi MC, Flegal KM, dietz WH, 2000 establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320: 1240-1243.
19. Chiotis d, Krikos X, Tsiftis G, Hatzisymeaon M, ManiatiChristidi M, dacou-voutetakis C, 2004 Body mass index and prevalence of obesity in subjects of Hellenic origin aged 0-18years, living in the athens area. ann Clin Paediatr univ atheniensis 51: 139-154.
20. Zimmet P, alberti KG, Kaufman F, et al, 2007 idF Consensus Group. The metabolic syndrome in children and adolescents-an idF consensus report. Pediatr diabetes 8: 299-306.
21. Tanner JM. 1962. Growth at adolescence. 2nd edn. oxford: Blackwell Scientific Publications.
22. Wallace TM, Levy JC, Matthews dr, 2004 use and abuse of HoMamodeling. diabetes Care 27: 1487-1495.
23. Pilarczyk K, Sattler KJ, Galili o, et al, 2008 Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization. atherosclerosis 196: 333-340.
24. roy H, Bhardwaj S, Ylä-Herttuala S, 2006 Biology of vascular endothelial growth factors. FeBS Lett 580: 2879-2887.
25. Wallace TW, abdullah SM, drazner MH, et al, 2006 Prevalence and determinants of troponin T elevation in the general population. Circulation 113: 1958-1965.
26. Pervanidou P, akalestos a, Sakka S, Kanaka-Gantenbein C, Papassotiriou i, Chrousos GP, 2010 Gender dimorphic associations between n-terminal pro-brain natriuretic peptide, body mass index and blood pressure in children and adolescents. Horm res Paediatr 73: 341-348.
27. Pervanidou P, Margeli a, akalestos a, et al, 2009 associations between circulating n-terminal pro-Brain natriuretic Peptide (nT-proBnP) and adiponectin concentrations depend on obesity level in female adolescents: gender dimorphic findings. Horm Metab res 41: 829-833.
28. Sorice r, ruggiero d, nutile T, et al, 2012 Genetic and environmental factors influencing the Placental Growth Factor (PGF) variation in two populations. PLoS one 7: e42537.
29. Goodman e, daniels Sr, Meigs JB, dolan LM, 2007 instability in the diagnosis of metabolic syndrome in adolescents. Circulation 115: 2316-2322.
30. Huang K, Zou CC, Yang XZ, Chen XQ, Liang L, 2010 Carotid intima-media thickness and serum endothelial marker levels in obese children with metabolic syndrome. arch Pediatr adolesc Med 164: 846-851.